Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.57 - $116.37 $2,514 - $2,909
-25 Closed
0 $0
Q2 2024

Nov 12, 2024

BUY
$103.94 - $118.98 $2,598 - $2,974
25 New
25 $2.66 Million
Q3 2023

Nov 13, 2023

SELL
$122.0 - $145.31 $2,196 - $2,615
-18 Closed
0 $0
Q1 2023

Nov 13, 2023

BUY
$133.98 - $160.47 $535 - $641
4 Added 28.57%
18 $2.62 Million
Q4 2021

Nov 13, 2023

BUY
$119.87 - $145.67 $1,678 - $2,039
14 New
14 $1.81 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.